TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › EPS (Diluted)TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — EPS (Diluted)Annual figures by period end, from SEC filings.2007-12-31: $2.362008-12-31: $0.752009-12-31: $2.232010-12-31: $3.672011-12-31: $3.092012-12-31: $2.252013-12-31: $1.492016-12-31: $0.072017-12-31: $-16.262018-12-31: $-2.352019-12-31: $-0.912020-12-31: $-3.642021-12-31: $0.382022-12-31: $-2.202023-12-31: $-0.502024-12-31: $-1.452025-12-31: $1.21$1.212007-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$1.21—2026-02-03From 2025-01-012024-12-31$-1.45—2026-02-03From 2024-01-012023-12-31$-0.50—2026-02-03From 2023-01-012022-12-31$-2.20-678.9%2025-02-05From 2022-01-012021-12-31$0.38—2024-02-12From 2021-01-012020-12-31$-3.64—2023-02-10From 2020-01-012019-12-31$-0.91—2022-02-09From 2019-01-012018-12-31$-2.35—2021-02-10From 2018-01-012017-12-31$-16.26-23328.6%2020-02-21From 2017-01-012016-12-31$0.07—2019-02-19From 2016-01-072013-12-31$1.49-33.8%2014-02-10From 2013-01-012012-12-31$2.25-27.2%2014-02-10From 2012-01-012011-12-31$3.09-15.8%2014-02-10From 2011-01-012010-12-31$3.67+64.6%2013-02-12From 2010-01-012009-12-31$2.23+197.3%2012-02-17From 2009-01-012008-12-31$0.75-68.2%2011-02-15From 2008-01-012007-12-31$2.36—2010-02-22From 2007-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)